INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $28,731 | -92.0% | 1,438 | -87.5% | 0.21% | +5050.0% |
| Q4 2017 | $358,000 | +32.6% | 11,494 | -26.6% | 0.00% | +33.3% |
| Q2 2017 | $270,000 | -45.0% | 15,662 | -44.1% | 0.00% | -40.0% |
| Q1 2017 | $491,000 | +24.3% | 28,033 | -6.1% | 0.01% | +66.7% |
| Q4 2016 | $395,000 | -8.8% | 29,843 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $433,000 | +43.9% | 29,843 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $301,000 | +21.4% | 29,843 | +52.2% | 0.00% | +50.0% |
| Q1 2016 | $248,000 | -42.7% | 19,602 | -17.8% | 0.00% | -50.0% |
| Q4 2015 | $433,000 | -3.1% | 23,833 | -1.0% | 0.00% | 0.0% |
| Q3 2015 | $447,000 | -69.4% | 24,083 | -59.8% | 0.00% | -63.6% |
| Q2 2015 | $1,462,000 | +63.9% | 59,854 | +39.6% | 0.01% | +57.1% |
| Q1 2015 | $892,000 | +23.0% | 42,868 | -8.5% | 0.01% | +40.0% |
| Q4 2014 | $725,000 | +19.0% | 46,857 | +0.5% | 0.01% | 0.0% |
| Q3 2014 | $609,000 | -38.6% | 46,630 | -6.1% | 0.01% | -28.6% |
| Q2 2014 | $992,000 | – | 49,654 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |